Skip to content
ScienceBlog.com
  • Featured Blogs
    • EU Horizon Blog
    • ESA Tracker
    • Experimental Frontiers
    • Josh Mitteldorf’s Aging Matters
    • Dr. Lu Zhang’s Gondwanaland
    • NeuroEdge
    • NIAAA
    • SciChi
    • The Poetry of Science
    • Wild Science
  • Topics
    • Brain & Behavior
    • Earth, Energy & Environment
    • Health
    • Life & Non-humans
    • Physics & Mathematics
    • Social Sciences
    • Space
    • Technology
  • Our Substack
  • Follow Us!
    • Bluesky
    • Threads
    • FaceBook
    • Google News
    • Twitter/X
  • Contribute/Contact

T

CD8 T cell priming occurs in two phases. In the activation phase (day 1), naïve T cells engage with dendritic cells (DC) for 24 hours, then detach, proliferate, and move deeper into the lymph node. In the selection phase (days 2-3), activated T cells regain sensitivity, re-engage with antigen-presenting cells, and receive IL-2 support from CD4 T cells. Regulatory T cells limit IL-2 availability, driving the expansion and differentiation of high-affinity CD8 T cells into effector cells.

Hidden Dance of T-Cells Reveals New Immune System Strategy Against Viruses

Krishanu Saha, right, works in a lab at the Wisconsin Institute for Discovery. Submitted photo

New ‘Keto Diet’ for T Cells Boosts Cancer-Fighting Power

cancer cells illustration

Secondary cancers following CAR T cell therapy are rare

The pulmonary distress associated with C-IRIS, an inflammatory condition that can affect immunocompromised patients, is caused not by damage to the lungs but by T-cells infiltrating the brain, University of Illinois researchers found. Comparative biosciences professor Makoto Inoue led the team. Photo by L. Brian Stauffer

T-cells infiltrate brain, cause respiratory distress in condition affecting the immunocompromised

Left to right: Professor Hiroki Ishikawa, Miho Tamai, and Masato Hirota from the Immune Signal Unit looked for associations between genes and proteins from blood immune cells and gut bacteria, and an individual’s immune response.

Gut bacteria could be behind weaker immune responses to COVID-19 vaccine

A new MIT study explains why dendritic cells (green) in lymph nodes that drain from the lungs fail to stimulate killer T cells (white) to attack lung tumors. Credits:Courtesy of the researchers

Why lung cancer doesn’t respond well to immunotherapy

Substack subscription form sign up

Comments

  • Simon on A New Theory Says DMT Entities Might Be Real, and Proposes How to Test It
  • Sue Ann Hayes on Hidden Nuclear Protein Fuels Pancreatic Cancer’s Deadly Aggression
  • Curtis Webber on The GPS-Killer? This Quantum Device ‘Feels’ Motion Like a Brain—Down to the Atomic Level
  • Ran on How the Age You First Had Sex Could Shape How You Age Decades Later
  • Sparty on How the Age You First Had Sex Could Shape How You Age Decades Later
© 2026 ScienceBlog.com | Follow our RSS / XML feed